On Apr. 27, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved PREVNAR 20®…
On Apr. 27, 2023, a National Institute of Allergy and Infectious Diseases (NIAID) -led Phase 2 trial compared two…
On Apr. 27, 2023, Zoonomia scientists announced they have have been cataloging the diversity in mammalian genomes by…
On Apr. 27, 2023, researchers at Cornell University announced they had used ancient DNA extraction and analysis to…
On Apr. 26, 2023, Vertex announced the Food and Drug Administration (FDA) had approved the expanded use of…
On Apr. 25, 2023, the U.S. U.S. Food and Drug Administration (FDA announced it had approved Qalsody (tofersen) to…
On Apr. 24, 2023, the U.S. Food and Drug Administration (FDA) authorized Status COVID-19 Antigen Rapid Test for…
On Apr. 24, 2023, Boehringer Ingelheim inaugurated its state-of-the-art Biologicals Development Center in Biberach an der Riss, Germany….
On Apr. 23, 2023, the most comprehensive state-by-state analysis of the impacts of COVID-19 across the USA, published…
On Apr. 20, 2023, Massachusetts Institute of Technology (MIT) researchers announced that have developed machine-learning algorithms that can…
On Apr. 18, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening for…
On Apr. 17, 2023, the World Health Organization (WHO) announced that six additional laboratory-confirmed cases of Marburg virus…
On Apr. 17, 2023, a new initiative led by Jennifer Doudna and Jill Banfield at the Innovative Genomics…
On Apr. 17, 2023, the U.S. Food and Drug Administration (FDA) approved Gamida Cell’s Omisirge (omidubicel-onlv), a substantially…
On Apr. 14, 2023, Revance Therapeutics announced that the U.S. Food and Drug Administration (FDA) had approved the…
On Apr. 13, 2023, in an enormous leap forward in the understanding of Parkinson’s disease (PD), researchers announced…
On Apr. 11, 2023, a National Institutes of Health (NIH) clinical trial was stopped early because a daily…
On Apr. 10, 2023, the U.S. Department of Health and Human Services (HHS) announced it was spending over…
On Apr. 10, 2023, the U.S. Food and Drug Administration (FDA) authorized for marketing Moximed’s MISHA Knee System,…
On Apr. 7, 2023, the U.S. National Park Service reported Highly Pathogenic Avian Influenza (HPAI) had been confirmed…
On Apr. 6, 2023, the Food and Agriculture Organization (FAO), in collaboration with the World Health Organization (WHO),…
On Apr. 5, 2023, researchers at Oregon Health & Science University’s OHSU Casey Eye Institue announced that gene…
On Apr. 5, 2023, Aberdeen Proving Ground South, formerly known as Edgewood, celebrated the opening of the Department…
On Apr. 5, 2023, Pfizer announced that experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing…
On Apr. 4, 2023, National Institutes of Health (NIH) funded research was announced from the University of Rochester…
On Apr. 4, 2023, NanoViricides announced that it had executed a license agreement with Karveer Meditech, Kolhapur, India,…
On Apr. 3, 2023, the U.S. Department of Health and Human Services (HHS) released a National Cancer Plan,…
On Apr. 3, 2023, a study from the National Eye Institute (NEI) identified rare genetic variants that could…
On Mar. 31, 2023, the Oregon Department of Agriculture and the United States Department of Agriculture’s Animal and…
On Mar. 30, 2023, Moderna and the Government of the Republic of Kenya announced they had finalized an…